Our Firm represents other Xarelto plaintiffs who are also alleged to have experienced life-threatening uncontrollable bleeding because of this blood thinner. We are closely monitoring this growing litigation.
New York, New York (PRWEB) November 21, 2014
Xarelto lawsuits (http://www.xareltolawsuit2015.com/) continue to be filed in U.S. courts on behalf of patients who allegedly suffered uncontrollable internal bleeding and other complications related to its use, Bernstein Liebhard LLP reports. Court documents filed in U.S. District Court, Southern District of Illinois, indicate an Illinois woman is seeking compensation from the manufacturers of Xarelto for damages she allegedly incurred due to life-threatening uterine hemorrhaging caused by the blood thinner. According to the October 10th complaint, the Plaintiff began taking Xarelto in November 2013, and was hospitalized with uterine bleeding just a few weeks later, during which time she required multiple blood transfusions. Among other things, the lawsuit alleges that the drug’s manufacturers did not adequately warn patients about the possibility of Xarelto bleeding, and that had the Plaintiff been informed of this risk, she would never have agreed to take the medication. (Case No. 3:2014cv00987)
“Our Firm represents other Xarelto plaintiffs who are also alleged to have experienced life-threatening uncontrollable bleeding because of this blood thinner. We are closely monitoring this growing litigation,” said Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free, no-obligation Xarelto case reviews to people who allegedly suffered serious injuries from the medication, including uncontrollable bleeding, strokes, deep vein thrombosis or pulmonary embolism.
Xarelto is a blood thinner that is approved by the U.S. Food & Drug Administration to prevent strokes in people with atrial fibrillation; as a treatment for deep vein thrombosis and pulmonary embolism; and to prevent deep vein thrombosis in patients undergoing hip or knee replacement surgery. Like any blood thinner, Xarelto can sometimes cause episodes of internal bleeding. However, there currently exists no approved antidote to reverse this potential complication.*
According to court documents, at least 30 Xarelto lawsuits have been filed in U.S. courts on behalf of individuals who were allegedly harmed by the drug. On December 4, 2014, the U.S Judicial Panel on Multidistrict Litigation (JPML) will hear Oral Arguments regarding a proposal to consolidate all federally-filed claims in a single court for coordinated pretrial-proceedings. (In Re: Xarelto Products Liability Litigation, No. 2592)
Individuals who were allegedly harmed by Xarelto may be entitled to compensation. To learn more about filing a Xarelto lawsuit, please visit Bernstein Liebhard LLPs website, or call 800-511-5092 to schedule a free, no obligation case review.
*fda.gov/downloads/Drugs/DrugSafety/UCM280333.pdf, FDA, March 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP